Video

Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations

Author(s):

Rodney Rohde, SV, SM, MB (ASCP), FACSc,Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Credit: Pexels/ cottonbro studio
December 12th 2024

Micro-Factors May Explain the Connection Between COVID-19, Schizophrenia

Chelsie Derman
COVID-19 Cases Are Climbing, with Donald Alcendor, PhD
September 1st 2023

COVID-19 Cases Are Climbing, with Donald Alcendor, PhD

Kevin Kunzmann
Anthony Back, MD I UW Medicine
December 6th 2024

Psilocybin Therapy Eases Clinicians' Depression Post-COVID Frontline Work

Chelsie Derman
Long COVID Research and Breakthroughs with Julia Moore Vogel, PhD, MBA
July 17th 2023

Long COVID Research and Breakthroughs with Julia Moore Vogel, PhD, MBA

Kevin Kunzmann
Children with IBD Respond Well to the Pfizer COVID-19 Vaccination, with Arthur Kastl, MD
November 21st 2024

Children with IBD Respond Well to the Pfizer COVID-19 Vaccination, with Arthur Kastl, MD

Chelsie Derman
COVID-19 Pandemic Linked to 29% Higher Risk of Dyslipidemia, Study Finds| Image Credit: Albert Einstein College of Medicine
November 7th 2024

COVID-19 Pandemic Linked to 29% Higher Risk of Dyslipidemia, Study Finds

Connor Iapoce
© 2024 MJH Life Sciences

All rights reserved.